Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B

Wenjun Wang(Wannan Medical College), Mingzhao Zhu(Chinese Academy of Sciences)

Nature Nanotechnology

March 2, 2020

10.1038/s41565-020-0648-y

Cited by 234

Related Papers

Matrix stiffness regulates tumor cell intravasation through expression and ESRP1-mediated alternative splicing of MENA

|Cell Reports|2023|28

Intraepithelial lymphocytes promote intestinal regeneration through CD160/HVEM signaling

|Mucosal Immunology|2024|18

Diabetic hyperglycemia-induced glycation regulates tumor vasculature integrity via NF-κB-mediated GM-CSF secretion by tumor cells

|Cell Biomaterials|2025|2

Multivalent nanoparticles activate T-dependent antibody response via antigen presentation by both B cells and dendritic cells

|Cell Reports|2026|0